跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZYPREXA 10 MG COMPRIMIDOS RECUBIERTOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ZYPREXA 10 MG COMPRIMIDOS RECUBIERTOS
Approved
STANDARD
ZYPREXA 10 MG COMPRIMIDOS RECUBIERTOS
Eli Lilly Nederland B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 29, 2023
Approval ID
f2d3adc1aa45a414
Company
Eli Lilly Nederland B.V.
Type
Standard
Approval Details
Approval Id
f2d3adc1aa45a414
Drug Cima Aemps Name
ZYPREXA 10 MG COMPRIMIDOS RECUBIERTOS
Register Number
96022010IP1
Holder Company Name
Eli Lilly Nederland B.V.
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/eli-lilly-nederland-bv
Authorization Date
2023-09-29
Dosage Form
COMPRIMIDO
Dose
10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Eli Lilly Nederland B.V.
Company Detail Path
/organization/eli-lilly-nederland-bv
Company Information
Pharmaceutical Company Name
Eli Lilly Nederland BV
Country Name
Netherlands
Website
http://www.lilly.com/nl
Active Ingredients
OLANZAPINA
10 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 29, 2023
Approval ID
f2d3adc1aa45a414
Type
Standard
Back to CIMA-AEMPS Approvals